32710539|t|Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.
32710539|a|BACKGROUND: The most common psychiatric complications due to dopaminergic treatment in Parkinson's disease are visual hallucinations and impulse control disorders. Their development depends on clinical and genetic factors. METHODS: We evaluated the simultaneous effect of 16 clinical and 34 genetic variables on the occurrence of visual hallucinations and impulse control disorders. Altogether, 214 Parkinson's disease patients were enrolled. Their demographic, clinical, and genotype data were obtained. Clinical and clinical-pharmacogenetic models were built by The Least Absolute Shrinkage and Selection Operator penalized logistic regression. The predictive capacity was evaluated with the cross-validated area under the receiver operating characteristic curve (AUC). RESULTS: The clinical-pharmacogenetic index for prediction of visual hallucinations encompassed age at diagnosis (OR = 0.99), rapid eye movement (REM) sleep behavior disorder (OR = 2.27), depression (OR = 1.0002), IL6 rs1800795 (OR = 0.99), GPX1 s1050450 (OR = 1.07), COMT rs165815 (OR = 0.69), MAOB rs1799836 (OR = 0.97), DRD3 rs6280 (OR = 1.32), and BIRC5 rs8073069 (OR = 0.94). The clinical-pharmacogenetic index for prediction of impulse control disorders encompassed age at diagnosis (OR = 0.95), depression (OR = 1.75), beta-blockers (OR = 0.99), coffee consumption (OR = 0.97), NOS1 rs2682826 (OR = 1.15), SLC6A3 rs393795 (OR = 1.27), SLC22A1 rs628031 (OR = 1.19), DRD2 rs1799732 (OR = 0.88), DRD3 rs6280 (OR = 0.88), and NRG1 rs3924999 (OR = 0.96). The cross-validated AUCs of clinical and clinical-pharmacogenetic models for visual hallucinations were 0.60 and 0.59, respectively. The AUCs of clinical and clinical-pharmacogenetic models for impulse control disorders were 0.72 and 0.71, respectively. The AUCs show that the addition of selected genetic variables to the analysis does not contribute to better prediction of visual hallucinations and impulse control disorders. CONCLUSIONS: Models could be improved by a larger cohort and by addition of other types of Parkinson's disease biomarkers to the analysis.
32710539	79	104	Psychiatric Complications	Disease	MESH:D001523
32710539	112	124	Dopaminergic	Chemical	MESH:D004298
32710539	138	157	Parkinson's Disease	Disease	MESH:D010300
32710539	187	212	psychiatric complications	Disease	MESH:D001523
32710539	220	232	dopaminergic	Chemical	MESH:D004298
32710539	246	265	Parkinson's disease	Disease	MESH:D010300
32710539	270	291	visual hallucinations	Disease	MESH:D006212
32710539	296	321	impulse control disorders	Disease	MESH:D007174
32710539	489	510	visual hallucinations	Disease	MESH:D006212
32710539	515	540	impulse control disorders	Disease	MESH:D007174
32710539	558	577	Parkinson's disease	Disease	MESH:D010300
32710539	578	586	patients	Species	9606
32710539	993	1014	visual hallucinations	Disease	MESH:D006212
32710539	1057	1105	rapid eye movement (REM) sleep behavior disorder	Disease	MESH:D020187
32710539	1119	1129	depression	Disease	MESH:D003866
32710539	1145	1148	IL6	Gene	3569
32710539	1149	1158	rs1800795	SNP	tmVar:rs1800795;VariantGroup:9;CorrespondingGene:3569;RS#:1800795;CorrespondingSpecies:9606
32710539	1172	1176	GPX1	Gene	2876
32710539	1199	1203	COMT	Gene	1312
32710539	1204	1212	rs165815	SNP	tmVar:rs165815;VariantGroup:7;CorrespondingGene:421;RS#:165815;CorrespondingSpecies:9606
32710539	1226	1230	MAOB	Gene	4129
32710539	1231	1240	rs1799836	SNP	tmVar:rs1799836;VariantGroup:5;CorrespondingGene:4129;RS#:1799836;CorrespondingSpecies:9606
32710539	1254	1258	DRD3	Gene	1814
32710539	1259	1265	rs6280	SNP	tmVar:rs6280;VariantGroup:3;CorrespondingGene:1814;RS#:6280;CorrespondingSpecies:9606
32710539	1283	1288	BIRC5	Gene	332
32710539	1289	1298	rs8073069	SNP	tmVar:rs8073069;VariantGroup:8;CorrespondingGene:332;RS#:8073069;CorrespondingSpecies:9606
32710539	1365	1390	impulse control disorders	Disease	MESH:D007174
32710539	1433	1443	depression	Disease	MESH:D003866
32710539	1516	1520	NOS1	Gene	4842
32710539	1521	1530	rs2682826	SNP	tmVar:rs2682826;VariantGroup:0;CorrespondingGene:4842;RS#:2682826;CorrespondingSpecies:9606
32710539	1544	1550	SLC6A3	Gene	6531
32710539	1551	1559	rs393795	SNP	tmVar:rs393795;VariantGroup:6;CorrespondingGene:6531;RS#:393795;CorrespondingSpecies:9606
32710539	1573	1580	SLC22A1	Gene	6580
32710539	1581	1589	rs628031	SNP	tmVar:rs628031;VariantGroup:1;CorrespondingGene:6580;RS#:628031;CorrespondingSpecies:9606
32710539	1603	1607	DRD2	Gene	1813
32710539	1608	1617	rs1799732	SNP	tmVar:rs1799732;VariantGroup:4;CorrespondingGene:1813;RS#:1799732;CorrespondingSpecies:9606
32710539	1631	1635	DRD3	Gene	1814
32710539	1636	1642	rs6280	SNP	tmVar:rs6280;VariantGroup:3;CorrespondingGene:1814;RS#:6280;CorrespondingSpecies:9606
32710539	1660	1664	NRG1	Gene	3084
32710539	1665	1674	rs3924999	SNP	tmVar:rs3924999;VariantGroup:2;CorrespondingGene:3084;RS#:3924999;CorrespondingSpecies:9606
32710539	1765	1786	visual hallucinations	Disease	MESH:D006212
32710539	1882	1907	impulse control disorders	Disease	MESH:D007174
32710539	2064	2085	visual hallucinations	Disease	MESH:D006212
32710539	2090	2115	impulse control disorders	Disease	MESH:D007174
32710539	2208	2227	Parkinson's disease	Disease	MESH:D010300
32710539	Association	MESH:D006212	RS#:165815;CorrespondingGene:421
32710539	Association	MESH:D007174	RS#:628031;CorrespondingGene:6580
32710539	Positive_Correlation	MESH:D006212	RS#:1799836;CorrespondingGene:4129
32710539	Association	MESH:D007174	6531
32710539	Association	MESH:D007174	RS#:393795;CorrespondingGene:6531
32710539	Positive_Correlation	MESH:D004298	MESH:D001523
32710539	Association	MESH:D006212	RS#:1800795;CorrespondingGene:3569
32710539	Association	MESH:D007174	RS#:1799732;CorrespondingGene:1813
32710539	Association	MESH:D007174	RS#:3924999;CorrespondingGene:3084
32710539	Association	MESH:D007174	3084
32710539	Positive_Correlation	MESH:D004298	MESH:D007174
32710539	Association	MESH:D007174	RS#:6280;CorrespondingGene:1814
32710539	Positive_Correlation	MESH:D006212	RS#:6280;CorrespondingGene:1814
32710539	Association	MESH:D006212	3569
32710539	Positive_Correlation	MESH:D007174	RS#:1800795;CorrespondingGene:3569
32710539	Positive_Correlation	MESH:D006212	RS#:8073069;CorrespondingGene:332
32710539	Positive_Correlation	MESH:D004298	MESH:D006212
32710539	Association	MESH:D006212	4129
32710539	Association	MESH:D006212	2876
32710539	Association	MESH:D007174	RS#:2682826;CorrespondingGene:4842
32710539	Association	MESH:D007174	6580
32710539	Association	MESH:D006212	332
32710539	Association	MESH:D007174	4842
32710539	Association	MESH:D006212	1814
32710539	Association	MESH:D006212	1312
32710539	Negative_Correlation	MESH:D004298	MESH:D010300
32710539	Association	MESH:D007174	1814
32710539	Association	MESH:D007174	1813
32710539	Association	MESH:D006212	421
32710539	Association	MESH:D007174	6580
32710539	Association	MESH:D006212	4129
32710539	Association	MESH:D007174	6531
32710539	Association	MESH:D006212	3569
32710539	Association	MESH:D007174	1813
32710539	Association	MESH:D007174	3084
32710539	Association	MESH:D007174	1814
32710539	Association	MESH:D006212	1814
32710539	Association	MESH:D007174	3569
32710539	Association	MESH:D006212	332
32710539	Association	MESH:D007174	4842

